carbamazepine vs efavirenz/emtricitabine/tenofovir

PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.

Side-by-side comparison of carbamazepine and efavirenz/emtricitabine/tenofovir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Anticonvulsants: Carbamazepine ↓ carbamazepine * ↓ efavirenz * There are insufficient data to make a dose recommendation for efavirenz.

Drug Class
carbamazepine Anticonvulsant
efavirenz/emtricitabine/tenofovir NNRTI / NRTI Combination
Type
carbamazepine Prescription
efavirenz/emtricitabine/tenofovir Prescription
Summary
carbamazepine

Carbamazepine is a medicine used to control seizures and treat nerve pain. It works by reducing abnormal electrical activity in the brain and calming nerve signals.

efavirenz/emtricitabine/tenofovir

Efavirenz is a drug used to treat HIV-1 infection. It belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTI).

What It Treats
carbamazepine

Carbamazepine is used to treat certain types of seizures, including partial seizures and generalized tonic-clonic seizures. It can also treat mixed seizure patterns. Carbamazepine also treats the pain from trigeminal neuralgia, a nerve disorder that causes intense facial pain. It is also sometimes used for glossopharyngeal neuralgia.

efavirenz/emtricitabine/tenofovir

Efavirenz is used to treat HIV-1, the virus that causes AIDS. It helps to lower the amount of virus in your body. This medicine must be used with other HIV medicines.

How It Works
carbamazepine

Carbamazepine is an anticonvulsant. It works by reducing the spread of seizure activity in the brain. It also stabilizes nerve impulses to reduce pain.

efavirenz/emtricitabine/tenofovir

Efavirenz blocks an enzyme called reverse transcriptase. HIV needs this enzyme to make copies of itself. By blocking it, efavirenz helps to slow down the spread of HIV in your body.

Common Side Effects
carbamazepine
  • Dizziness
  • Drowsiness
  • Unsteadiness
  • Nausea
  • Vomiting
efavirenz/emtricitabine/tenofovir
  • Rash
  • Dizziness
  • Nausea
  • Headache
  • Fatigue
FAERS Reports
carbamazepine
  • Seizure 3,609
  • Drug Interaction 3,369
  • Fall 3,044
  • Dizziness 2,862
  • Pyrexia 2,689
efavirenz/emtricitabine/tenofovir
  • Virologic Failure 952
  • Drug Interaction 748
  • Drug Resistance 735
  • Viral Mutation Identified 674
  • Pathogen Resistance 623
Serious Warnings
carbamazepine

Carbamazepine can cause severe skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be fatal. If you are of Asian descent, you may need a blood test before starting this medicine. Carbamazepine can also cause serious blood problems like aplastic anemia and agranulocytosis. Contact your doctor right away if you develop a fever, sore throat, rash, or unusual bleeding or bruising.

efavirenz/emtricitabine/tenofovir

Efavirenz can cause serious side effects, including psychiatric problems like depression or suicidal thoughts. Tell your doctor right away if you have any of these symptoms. Efavirenz can also harm your liver. Your doctor should check your liver function before and during treatment. Do not take efavirenz by itself.

Pregnancy
carbamazepine

Carbamazepine may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if carbamazepine passes into breast milk, so talk to your doctor about breastfeeding.

efavirenz/emtricitabine/tenofovir

Efavirenz can harm your unborn baby, especially during the first 3 months of pregnancy. Talk to your doctor about using birth control while taking this medicine. Breastfeeding is not recommended while taking efavirenz.

Also Compare, Nearby Drugs

How to Read This carbamazepine vs efavirenz/emtricitabine/tenofovir Comparison

carbamazepine is classified in the Anticonvulsant drug class, while efavirenz/emtricitabine/tenofovir sits within the NNRTI / NRTI Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, carbamazepine has 15,573 submissions while efavirenz/emtricitabine/tenofovir has 3,732. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these two drugs cause each other to be cleared from your body faster, lowering the levels of both medicines.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for carbamazepine or efavirenz/emtricitabine/tenofovir.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.